跳至主要内容
临床试验/NCT04153110
NCT04153110已完成不适用

Cerebello-Spinal tDCS as Rehabilitative Intervention in Neurodegenerative Ataxias: a Randomized, Double-blind, Sham-controlled Trial Followed by an Open-label Phase

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia2 个研究点 分布在 1 个国家目标入组 61 人开始时间: 2018年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
61
试验地点
2
主要终点
Change in the International Cooperative Ataxia Rating Scale (ICARS) Score From Baseline

研究概览

简要总结

Neurodegenerative cerebellar ataxias represent a group of disabling disorders which currently lack effective therapies. Cerebellar transcranial direct current stimulation (tDCS) is a non-invasive technique, which has been demonstrated to modulate cerebellar excitability and improve symptoms in patients with cerebellar ataxias. In this randomized, double-blind, sham-controlled study followed by an open-label phase, the investigators will evaluate whether a repetition of two-weeks' treatment with cerebellar anodal tDCS and spinal cathodal tDCS, after a three months interval, may further outlast clinical improvement in patients with neurodegenerative cerebellar ataxia and can modulate cerebello-motor connectivity, at short and long term.

详细描述

Neurodegenerative cerebellar ataxias represent a heterogeneous group of disabling disorders in which progressive ataxia of gait, limb dysmetria, oculomotor deficits, dysarthria and kinetic tremor are the prominent clinical manifestations. Both the hereditary and sporadic forms usually present in young adulthood, and are characterized by atrophy of cerebellar or brainstem structures. Currently, cerebellar ataxia lack effective disease-modifying therapies.

Cerebellar transcranial direct current stimulation (tDCS) is a non-invasive technique, which has been demonstrated to modulate cerebellar excitability and improve symptoms in patients with cerebellar ataxias. The present randomized, double-blind, sham-controlled study followed by an open-label phase will investigate a repetition of two-weeks' treatment with cerebellar anodal tDCS and spinal cathodal tDCS, after a three months interval, may further outlast clinical improvement in patients with neurodegenerative cerebellar ataxia and can modulate cerebello-motor connectivity, at short and long term. In addition the investigators will evaluate if tDCS intervention might improve cerebellar cognitive-affective syndrome in patients with ataxia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with a cerebellar syndrome and quantifiable cerebellar atrophy

排除标准

  • Severe head trauma in the past
  • History of seizures
  • History of ischemic stroke or hemorrhage
  • Pacemaker
  • Metal implants in the head/neck region
  • Severe comorbidity
  • Intake of illegal drugs
  • Pregnancy

结局指标

主要结局

Change in the International Cooperative Ataxia Rating Scale (ICARS) Score From Baseline

时间窗: Baseline - 2 weeks

International Cooperative Ataxia Rating Scale (ICARS): semi-quantitative 100-point scale, yielding a total score of 0 (no ataxia) to 100 (most severe ataxia).

Change in the Scale for the Assessment and Rating of Ataxia (SARA) Score From Baseline

时间窗: Baseline - 2 weeks

Scale for the Assessment and Rating of Ataxia (SARA): 8-item performance based scale, yielding a total score of 0 (no ataxia) to 40 (most severe ataxia).

Change in the Cerebellar cognitive affective syndrome (CCAS) Scale From Baseline

时间窗: Baseline - 2 weeks

CCAS/Schmahmann syndrome scale: 120 point scale, yielding a total score of 0 (most severe cognitive impairment) to 120 (no cognitive impairment).

次要结局

  • Change in the Short-Form Health Survey 36 (SF36) Score From Baseline(Baseline - 2 weeks - 3 month - 6 months - 9 months)
  • Change in the Cerebellar cognitive affective syndrome (CCAS) Scale From Baseline(Baseline - 2 weeks - 3 month - 6 months - 9 months)
  • Change in the International Cooperative Ataxia Rating Scale (ICARS) Score From Baseline(Baseline - 2 weeks - 3 month - 6 months - 9 months)
  • Change in the Scale for the Assessment and Rating of Ataxia (SARA) Score From Baseline(Baseline - 2 weeks - 3 month - 6 months - 9 months)
  • Change in Cerebellar Brain Inhibition (CBI) Measurements From Baseline(Baseline - 2 weeks - 3 month - 6 months - 9 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Barbara Borroni

Professor

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

研究点 (2)

Loading locations...

相似试验

Cerebello-Spinal tDCS as Rehabilitative Intervention... | 临床试验